St. Jude Medical Inc. will pay $39 million to Kensey Nash Corp. in 12 equal quarterly payments beginning March 31 in lieu of all future royalties relating to Angio-Seal vascular closure devices and related claims to resolve the firms’ ongoing royalties dispute, Kensey Nash reported March 16. In addition, Kensey Nash will continue to be the exclusive outside supplier of collagen for the Angio-Seal device through 2017, with minimum orders of $31 million over the five-year extension, according to the company. The mediated settlement comes three months after the firms agreed to enter non-binding mediation talks to resolve their license disputes. (See Also see "News In Brief" - Medtech Insight, 2 January, 2012..)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?